Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Feb;75(2):275–279.

Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?

R van der Gaag 1, L Broersma 1, M P Mourits 1, L Koornneef 1, W M Wiersinga 1, M P Prummel 1, A Berghout 1
PMCID: PMC1542113  PMID: 2649288

Abstract

A factor which inhibits the random migration of monocytes in vitro was found in the serum of nearly half of Graves' ophthalmopathy patients. This factor was found in serum of only 4% of the healthy controls. When the Graves' ophthalmopathy patients were subdivided, on clinical criteria (pain, redness, swelling and impaired function), into patients with active disease and patients with inactive disease, the serum factor was found in 61% of the patients with active inflammatory disease and only in 14% of the patients with inactive disease. Furthermore this factor was also found in the serum of patients with an acute episode of uveitis, suggesting that it may be a useful marker for assessment of a localized inflammatory process.

Full text

PDF
275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker A. S. Editorial: Primary care by the nurse. N Engl J Med. 1974 Jan 31;290(5):282–283. doi: 10.1056/NEJM197401312900514. [DOI] [PubMed] [Google Scholar]
  2. Bianco C., Götze O., Cohn Z. A. Regulation of macrophage migration by products of the complement system. Proc Natl Acad Sci U S A. 1979 Feb;76(2):888–891. doi: 10.1073/pnas.76.2.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brakenhoff J. P., de Groot E. R., Evers R. F., Pannekoek H., Aarden L. A. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol. 1987 Dec 15;139(12):4116–4121. [PubMed] [Google Scholar]
  4. Kendall-Taylor P. The pathogenesis of Graves' ophthalmopathy. Clin Endocrinol Metab. 1985 May;14(2):331–349. doi: 10.1016/s0300-595x(85)80037-2. [DOI] [PubMed] [Google Scholar]
  5. Klinkert W., Sorg C. Characterization of four lymphocyte activation products of guinea pig and their association with macrophage migration inhibitory activity (MIF). Mol Immunol. 1980 May;17(5):555–564. doi: 10.1016/0161-5890(80)90153-4. [DOI] [PubMed] [Google Scholar]
  6. Malorny U., Knop J., Burmeister G., Sorg C. Immunohistochemical demonstration of migration inhibitory factor (MIF) in experimental allergic contact dermatitis. Clin Exp Immunol. 1988 Jan;71(1):164–170. [PMC free article] [PubMed] [Google Scholar]
  7. Mashieu P., Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab. 1972 Jun;34(6):1090–1092. doi: 10.1210/jcem-34-6-1090. [DOI] [PubMed] [Google Scholar]
  8. Mullin B. R., Levinson R. E., Friedman A., Henson D. E., Winand R. J., Kohn L. D. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology. 1977 Feb;100(2):351–366. doi: 10.1210/endo-100-2-351. [DOI] [PubMed] [Google Scholar]
  9. Neumann C., Schlegel R., Steckel F., Sorg C. Detection of macrophage migration inhibitory factor by monoclonal antibody in Sézary syndrome. J Invest Dermatol. 1987 Jun;88(6):670–674. doi: 10.1111/1523-1747.ep12470326. [DOI] [PubMed] [Google Scholar]
  10. Neumann C., Sorg C. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon. Eur J Immunol. 1978 Aug;8(8):582–589. doi: 10.1002/eji.1830080809. [DOI] [PubMed] [Google Scholar]
  11. Rea T. H., Yoshida T. Serum macrophage migration inhibition activity in patients with leprosy. J Invest Dermatol. 1982 Nov;79(5):336–339. doi: 10.1111/1523-1747.ep12500088. [DOI] [PubMed] [Google Scholar]
  12. Salvin S. B., Ribi E., Granger D. L., Youngner J. S. Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components. J Immunol. 1975 Jan;114(1 Pt 2):354–359. [PubMed] [Google Scholar]
  13. Salvin S. B., Youngner J. S., Lederer W. H. Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect Immun. 1973 Jan;7(1):68–75. doi: 10.1128/iai.7.1.68-75.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Weiser W. Y., Greineder D. K., Remold H. G., David J. R. Studies on human migration inhibitory factor: characterization of three molecular species. J Immunol. 1981 May;126(5):1958–1962. [PubMed] [Google Scholar]
  15. Werner S. C. Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol. 1977 May;83(5):725–727. doi: 10.1016/0002-9394(77)90140-4. [DOI] [PubMed] [Google Scholar]
  16. Wiersinga W. M., Touber J. L. Thyroid function tests. II. Studies in patients with thyroid diseases. Neth J Med. 1980;23(5):200–209. [PubMed] [Google Scholar]
  17. Yoshida T., Edelson R., Cohen S., Green I. Migration inhibitory activity in serum and cell supernatants in patients with Sezary syndrome. J Immunol. 1975 Mar;114(3):915–918. [PubMed] [Google Scholar]
  18. Yoshida T., Siltzbach L. E., Masih N., Cohen S. Serum-migration inhibitory activity in patients with sarcoidosis. Clin Immunol Immunopathol. 1979 May;13(1):39–46. doi: 10.1016/0090-1229(79)90018-7. [DOI] [PubMed] [Google Scholar]
  19. van de Plassche-Boers E. M., Drexhage H. A., Kokjé-Kleingeld M., Leezenberg H. A. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay. Clin Exp Immunol. 1986 Dec;66(3):516–524. [PMC free article] [PubMed] [Google Scholar]
  20. van der Gaag R., Broersma L., Koornneef L. The influence of high molecular weight sodium hyaluronate (Healon) on the production of migration inhibitory factor. Curr Eye Res. 1987 Dec;6(12):1433–1440. doi: 10.3109/02713688709044507. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES